Mark N. Feinglos, MD, CM, professor of medicine (Endocrinology, Metabolism and Nutrition) and associate professor of Pathology and Psychiatry and Behavioral Sciences, is part of a team of Duke researchers who have developed a new method to overcome major hurdles facing a promising new class of peptide drugs to treat diseases such as diabetes and cancer.